Agarwal, R. et al. Chlorthalidone for hypertension in advanced chronic kidney disease. N. Engl. J. Med. 385, 2507–2519 (2021).
Georgianos, P. I. & Agarwal, R. Hypertension in chronic kidney disease-treatment standard 2023. Nephrol. Dial. Transplant. 38, 2694–2703 (2023).
Moes, A. D., Hesselink, D. A., van den Meiracker, A. H., Zietse, R. & Hoorn, E. J. Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial. Am. J. Kidney Dis. 69, 796–804 (2017).
Taber, D. J. et al. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am. J. Nephrol. 38, 285–291 (2013).
Kramers, B. J. et al. Effects of hydrochlorothiazide and metformin on aquaresis and nephroprotection by a vasopressin v2 receptor antagonist in ADPKD: a randomized crossover trial. Clin. J. Am. Soc. Nephrol. 17, 507–517 (2022).
Shao, S. C. et al. Associations of thiazide use with skin cancers: a systematic review and meta-analysis. BMC Med. 20, 228 (2022).
VanWormer, J. J., Abokede, E. B. & Berg, R. L. Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer. BMC Public Health 22, 1282 (2022).
Fuhrmann, J. D. et al. Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term. Clin. Kidney J. 15, 1152–1159 (2022).
Letellier, T. et al. Association between use of hydrochlorothiazide and risk of keratinocyte cancers in kidney transplant recipients. Clin. J. Am. Soc. Nephrol. 15, 1804–1813 (2020).
Bretagnol, A. et al. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation. Transpl. Int. 23, 878–886 (2010).
Nazarzadeh, M. et al. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet 398, 1803–1810 (2021).
Kucharczyk, P. et al. Thiazides attenuate insulin secretion through inhibition of mitochondrial carbonic anhydrase 5b in β-islet cells in mice. J. Am. Soc. Nephrol. 34, 1179–1190 (2023).
Sokooti, S. et al. Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients. Nephrol. Dial. Transplant. 37, 1375–1383 (2022).
de Mattos, A. M. et al. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney Int. 67, 714–720 (2005).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41581-024-00839-9